Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Narcotic (Opioid) Drugs Market Size Analysis from 2022 to 2027

1.5.1 Global Narcotic (Opioid) Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Narcotic (Opioid) Drugs Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Narcotic (Opioid) Drugs Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Narcotic (Opioid) Drugs Industry Impact

Chapter 2 Global Narcotic (Opioid) Drugs Competition by Types, Applications, and Top Regions and Countries

2.1 Global Narcotic (Opioid) Drugs (Volume and Value) by Type

2.1.1 Global Narcotic (Opioid) Drugs Consumption and Market Share by Type (2016-2021)

2.1.2 Global Narcotic (Opioid) Drugs Revenue and Market Share by Type (2016-2021)

2.2 Global Narcotic (Opioid) Drugs (Volume and Value) by Application

2.2.1 Global Narcotic (Opioid) Drugs Consumption and Market Share by Application (2016-2021)

2.2.2 Global Narcotic (Opioid) Drugs Revenue and Market Share by Application (2016-2021)

2.3 Global Narcotic (Opioid) Drugs (Volume and Value) by Regions

2.3.1 Global Narcotic (Opioid) Drugs Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Narcotic (Opioid) Drugs Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Narcotic (Opioid) Drugs Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Narcotic (Opioid) Drugs Consumption by Regions (2016-2021)

4.2 North America Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

4.10 South America Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Narcotic (Opioid) Drugs Market Analysis

5.1 North America Narcotic (Opioid) Drugs Consumption and Value Analysis

5.1.1 North America Narcotic (Opioid) Drugs Market Under COVID-19

5.2 North America Narcotic (Opioid) Drugs Consumption Volume by Types

5.3 North America Narcotic (Opioid) Drugs Consumption Structure by Application

5.4 North America Narcotic (Opioid) Drugs Consumption by Top Countries

5.4.1 United States Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

5.4.2 Canada Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

5.4.3 Mexico Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 6 East Asia Narcotic (Opioid) Drugs Market Analysis

6.1 East Asia Narcotic (Opioid) Drugs Consumption and Value Analysis

6.1.1 East Asia Narcotic (Opioid) Drugs Market Under COVID-19

6.2 East Asia Narcotic (Opioid) Drugs Consumption Volume by Types

6.3 East Asia Narcotic (Opioid) Drugs Consumption Structure by Application

6.4 East Asia Narcotic (Opioid) Drugs Consumption by Top Countries

6.4.1 China Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

6.4.2 Japan Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

6.4.3 South Korea Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 7 Europe Narcotic (Opioid) Drugs Market Analysis

7.1 Europe Narcotic (Opioid) Drugs Consumption and Value Analysis

7.1.1 Europe Narcotic (Opioid) Drugs Market Under COVID-19

7.2 Europe Narcotic (Opioid) Drugs Consumption Volume by Types

7.3 Europe Narcotic (Opioid) Drugs Consumption Structure by Application

7.4 Europe Narcotic (Opioid) Drugs Consumption by Top Countries

7.4.1 Germany Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

7.4.2 UK Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

7.4.3 France Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

7.4.4 Italy Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

7.4.5 Russia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

7.4.6 Spain Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

7.4.7 Netherlands Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

7.4.8 Switzerland Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

7.4.9 Poland Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 8 South Asia Narcotic (Opioid) Drugs Market Analysis

8.1 South Asia Narcotic (Opioid) Drugs Consumption and Value Analysis

8.1.1 South Asia Narcotic (Opioid) Drugs Market Under COVID-19

8.2 South Asia Narcotic (Opioid) Drugs Consumption Volume by Types

8.3 South Asia Narcotic (Opioid) Drugs Consumption Structure by Application

8.4 South Asia Narcotic (Opioid) Drugs Consumption by Top Countries

8.4.1 India Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

8.4.2 Pakistan Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Narcotic (Opioid) Drugs Market Analysis

9.1 Southeast Asia Narcotic (Opioid) Drugs Consumption and Value Analysis

9.1.1 Southeast Asia Narcotic (Opioid) Drugs Market Under COVID-19

9.2 Southeast Asia Narcotic (Opioid) Drugs Consumption Volume by Types

9.3 Southeast Asia Narcotic (Opioid) Drugs Consumption Structure by Application

9.4 Southeast Asia Narcotic (Opioid) Drugs Consumption by Top Countries

9.4.1 Indonesia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

9.4.2 Thailand Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

9.4.3 Singapore Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

9.4.4 Malaysia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

9.4.5 Philippines Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

9.4.6 Vietnam Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

9.4.7 Myanmar Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 10 Middle East Narcotic (Opioid) Drugs Market Analysis

10.1 Middle East Narcotic (Opioid) Drugs Consumption and Value Analysis

10.1.1 Middle East Narcotic (Opioid) Drugs Market Under COVID-19

10.2 Middle East Narcotic (Opioid) Drugs Consumption Volume by Types

10.3 Middle East Narcotic (Opioid) Drugs Consumption Structure by Application

10.4 Middle East Narcotic (Opioid) Drugs Consumption by Top Countries

10.4.1 Turkey Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

10.4.3 Iran Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

10.4.5 Israel Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

10.4.6 Iraq Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

10.4.7 Qatar Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

10.4.8 Kuwait Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

10.4.9 Oman Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 11 Africa Narcotic (Opioid) Drugs Market Analysis

11.1 Africa Narcotic (Opioid) Drugs Consumption and Value Analysis

11.1.1 Africa Narcotic (Opioid) Drugs Market Under COVID-19

11.2 Africa Narcotic (Opioid) Drugs Consumption Volume by Types

11.3 Africa Narcotic (Opioid) Drugs Consumption Structure by Application

11.4 Africa Narcotic (Opioid) Drugs Consumption by Top Countries

11.4.1 Nigeria Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

11.4.2 South Africa Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

11.4.3 Egypt Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

11.4.4 Algeria Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

11.4.5 Morocco Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 12 Oceania Narcotic (Opioid) Drugs Market Analysis

12.1 Oceania Narcotic (Opioid) Drugs Consumption and Value Analysis

12.2 Oceania Narcotic (Opioid) Drugs Consumption Volume by Types

12.3 Oceania Narcotic (Opioid) Drugs Consumption Structure by Application

12.4 Oceania Narcotic (Opioid) Drugs Consumption by Top Countries

12.4.1 Australia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

12.4.2 New Zealand Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 13 South America Narcotic (Opioid) Drugs Market Analysis

13.1 South America Narcotic (Opioid) Drugs Consumption and Value Analysis

13.1.1 South America Narcotic (Opioid) Drugs Market Under COVID-19

13.2 South America Narcotic (Opioid) Drugs Consumption Volume by Types

13.3 South America Narcotic (Opioid) Drugs Consumption Structure by Application

13.4 South America Narcotic (Opioid) Drugs Consumption Volume by Major Countries

13.4.1 Brazil Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

13.4.2 Argentina Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

13.4.3 Columbia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

13.4.4 Chile Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

13.4.5 Venezuela Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

13.4.6 Peru Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

13.4.8 Ecuador Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Narcotic (Opioid) Drugs Business

14.1 Pfizer

14.1.1 Pfizer Company Profile

14.1.2 Pfizer Narcotic (Opioid) Drugs Product Specification

14.1.3 Pfizer Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Merck

14.2.1 Merck Company Profile

14.2.2 Merck Narcotic (Opioid) Drugs Product Specification

14.2.3 Merck Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Mallinckrodt

14.3.1 Mallinckrodt Company Profile

14.3.2 Mallinckrodt Narcotic (Opioid) Drugs Product Specification

14.3.3 Mallinckrodt Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Teva

14.4.1 Teva Company Profile

14.4.2 Teva Narcotic (Opioid) Drugs Product Specification

14.4.3 Teva Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Johnson & Johnson

14.5.1 Johnson & Johnson Company Profile

14.5.2 Johnson & Johnson Narcotic (Opioid) Drugs Product Specification

14.5.3 Johnson & Johnson Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Purdue Pharma

14.6.1 Purdue Pharma Company Profile

14.6.2 Purdue Pharma Narcotic (Opioid) Drugs Product Specification

14.6.3 Purdue Pharma Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Hikma Pharmaceuticals

14.7.1 Hikma Pharmaceuticals Company Profile

14.7.2 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Specification

14.7.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Collegium

14.8.1 Collegium Company Profile

14.8.2 Collegium Narcotic (Opioid) Drugs Product Specification

14.8.3 Collegium Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Amneal Pharma

14.9.1 Amneal Pharma Company Profile

14.9.2 Amneal Pharma Narcotic (Opioid) Drugs Product Specification

14.9.3 Amneal Pharma Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Mylan

14.10.1 Mylan Company Profile

14.10.2 Mylan Narcotic (Opioid) Drugs Product Specification

14.10.3 Mylan Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Sun Pharma

14.11.1 Sun Pharma Company Profile

14.11.2 Sun Pharma Narcotic (Opioid) Drugs Product Specification

14.11.3 Sun Pharma Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Endo Pharmaceuticals

14.12.1 Endo Pharmaceuticals Company Profile

14.12.2 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Specification

14.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Allergan

14.13.1 Allergan Company Profile

14.13.2 Allergan Narcotic (Opioid) Drugs Product Specification

14.13.3 Allergan Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Narcotic (Opioid) Drugs Market Forecast (2022-2027)

15.1 Global Narcotic (Opioid) Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Narcotic (Opioid) Drugs Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Narcotic (Opioid) Drugs Value and Growth Rate Forecast (2022-2027)

15.2 Global Narcotic (Opioid) Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Narcotic (Opioid) Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Narcotic (Opioid) Drugs Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Narcotic (Opioid) Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Narcotic (Opioid) Drugs Consumption Forecast by Type (2022-2027)

15.3.2 Global Narcotic (Opioid) Drugs Revenue Forecast by Type (2022-2027)

15.3.3 Global Narcotic (Opioid) Drugs Price Forecast by Type (2022-2027)

15.4 Global Narcotic (Opioid) Drugs Consumption Volume Forecast by Application (2022-2027)

15.5 Narcotic (Opioid) Drugs Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology